PAUKOVČEKOVÁ, Silvia, Dalibor VALÍK, Jaroslav ŠTĚRBA and Renata VESELSKÁ. Enhanced Antiproliferative Effect of Combined Treatment with Calcitriol and All-Trans Retinoic Acid in Relation to Vitamin D Receptor and Retinoic Acid Receptor alpha Expression in Osteosarcoma Cell Lines. International Journal of Molecular Sciences. Basel: MDPI, 2020, vol. 21, No 18, p. 1-19. ISSN 1422-0067. Available from: https://dx.doi.org/10.3390/ijms21186591.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Enhanced Antiproliferative Effect of Combined Treatment with Calcitriol and All-Trans Retinoic Acid in Relation to Vitamin D Receptor and Retinoic Acid Receptor alpha Expression in Osteosarcoma Cell Lines
Authors PAUKOVČEKOVÁ, Silvia (703 Slovakia, belonging to the institution), Dalibor VALÍK (203 Czech Republic, belonging to the institution), Jaroslav ŠTĚRBA (203 Czech Republic, belonging to the institution) and Renata VESELSKÁ (203 Czech Republic, guarantor, belonging to the institution).
Edition International Journal of Molecular Sciences, Basel, MDPI, 2020, 1422-0067.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10603 Genetics and heredity
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 5.923
RIV identification code RIV/00216224:14310/20:00117247
Organization unit Faculty of Science
Doi http://dx.doi.org/10.3390/ijms21186591
UT WoS 000580121900001
Keywords in English osteosarcoma; calcitriol; calcidiol; all-transretinoic acid; vitamin D receptor; retinoic acid receptor alpha
Tags 14110321, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Marie Šípková, DiS., učo 437722. Changed: 31/8/2021 16:27.
Abstract
The main objective of this study was to analyze changes in the antiproliferative effect of vitamin D3, in the form of calcitriol and calcidiol, via its combined application with all-transretinoic acid (ATRA) in osteosarcoma cell lines. The response to treatment with calcitriol and calcidiol alone was specific for each cell line. Nevertheless, we observed an enhanced effect of combined treatment with ATRA and calcitriol in the majority of the cell lines. Although the levels of respective nuclear receptors did not correlate with the sensitivity of cells to these drugs, vitamin D receptor (VDR) upregulation induced by ATRA was found in cell lines that were the most sensitive to the combined treatment. In addition, all these cell lines showed high endogenous levels of retinoic acid receptor alpha (RAR alpha). Our study confirmed that the combination of calcitriol and ATRA can achieve enhanced antiproliferative effects in human osteosarcoma cell lines in vitro. Moreover, we provide the first evidence that ATRA is able to upregulate VDR expression in human osteosarcoma cells. According to our results, the endogenous levels of RAR alpha and VDR could be used as a predictor of possible synergy between ATRA and calcitriol in osteosarcoma cells.
Links
LM2018128, research and development projectName: Český národní uzel Evropské sítě infrastruktur klinického výzkumu (Acronym: CZECRIN)
Investor: Ministry of Education, Youth and Sports of the CR
MUNI/A/1409/2019, interní kód MUName: Personalizovaná léčba v dětské onkologii: na cestě k "liquid dynamic medicine" a "N-of-1 clinical trials"
Investor: Masaryk University, Category A
PrintDisplayed: 4/5/2024 10:27